B. Metzler seel. Sohn & Co »

Arrowhead Pharmaceuticals shares owned by B. Metzler seel. Sohn & Co

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by B. Metzler seel. Sohn & Co from 13F filings

Historical chart of B. Metzler seel. Sohn & Co investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by B. Metzler seel. Sohn & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by B. Metzler seel. Sohn & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $535k 19k 28.60
2022-03-31 $472k 10k 45.97

More positions owned by B. Metzler seel. Sohn & Co

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Procter & Gamble Company (PG)
Coca-Cola Company (KO)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Johnson & Johnson (JNJ)
Palo Alto Networks (PANW)
S&p Global (SPGI)
Deere & Company (DE)
BlackRock (BLK)

View all positions for B. Metzler seel. Sohn & Co

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
FMR
Artal Group
Geode Capital Management
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Credit Suisse
Northern Trust
Rokos Capital Management
Pictet Asset Management Holding SA
Morgan Stanley
venBio Select Advisor
Bank of New York Mellon
Goldman Sachs Group

View all funds holding Arrowhead Pharmaceuticals